retatrutide studies Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide Peptide Guide (2026): The

Exenatide, cagrilinitide, orforglipron were not associated with diarrhea risk

A growing share of employers are rethinking coverage of the weight-loss drugs as costs rise and early expectations of lower obesity rates and surgical needs have yet to surface in claims data.

In diabetic mice, D13 and D41 demonstrated prolonged hypoglycemic effects

The current therapy associated with repeated subcutaneous injections to maintain the drug therapeutic effect causes patient compliance issues ...

While they are often discussed in the context of weight loss, their origins (and their impact) are rooted in deeper biological systems that regulate appetite, blood sugar, and energy balance

Learn what the evidence shows about muscle symptoms with semaglutide, tirzepatide, and other GLP-1 medications, plus when to contact your doctor and how to protect muscle mass during treatment.